We are a human-sized, international, and independent pharmaceutical group, governed by a Foundation. Our unique model is a source of pride, but above all, it allows us to fully serve our mission: “Committed to therapeutic progress for the benefit of patients.”

Today, a global leader in cardiology, we have chosen to become a focused and innovative player in oncology by 2030, targeting hard-to-treat cancers and dedicating more than 70% of our R&D budget to this area. We are committed to equal opportunities and the development of talent in all its diversity. We value both experience and the willingness to engage daily to contribute to therapeutic progress for the benefit of patients. If you see yourself reflected in this offer and these few lines, seize the opportunity to meet us. We pursue this challenge alongside the development of our generics business, ensuring access to quality care for all, at a lower cost.

Who are we? More than 20,000 passionate individuals from ...